Write in a clean editor, then format for Journal of the Renin-Angiotensin-Aldosterone System in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of the Renin-Angiotensin-Aldosterone System is a peer-reviewed journal published by SAGE, covering Renin-Angiotensin System Studies, Hormonal Regulation and Hypertension, Blood Pressure and Hypertension Studies.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Journal of the Renin-Angiotensin-Aldosterone System, 12(3), pp. 45–58.
Formats any DOI in Journal of the Renin-Angiotensin-Aldosterone System style. No sign-up. |
| Publishes research in | Renin-Angiotensin System Studies Hormonal Regulation and Hypertension Blood Pressure and Hypertension Studies Heart Failure Treatment and Management Chronic Kidney Disease and Diabetes |
| ISSN | 1470-3203 |
| Citation impact (2-yr) | 1.58 |
| h-index | 59 |
| i10-index | 712 |
| Total citations | 23,175 |
| Article processing charge | $2,100 |
| Top institutions publishing here | Brigham and Women's Hospital |
| Journal website | jra.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
More than a century of research on the reninangiotensin system (RAS) has uncovered the widespread involvement of angiotensin II (Ang II) in the pathophysiology of cardiovascular diseases. A number of outcomes-based mega trials utilising hard clinical endpoints have revealed beneficial effects of angiotensin receptor antagonists (AIIAs/ARBs) in patients with hypertension, heart failure, diabetic nephropathy, and…
OBJECTIVE: To assess the antihypertensive efficacy and safety of the combination of the direct renin inhibitor aliskiren and ramipril in patients with diabetes and hypertension. METHODS: In this double-blind, multicentre trial, 837 patients with diabetes mellitus and hypertension (mean sitting diastolic blood pressure [BP] > 95 and < 110 mmHg) were randomised to once-daily aliskiren…
Endothelins are a family of peptides, which comprises endothelin-1 (ET-1), endothelin-2 (ET-2) and endothelin-3 (ET-3), each containing 21 amino-acids. ET-1 is a peptide secreted mostly by vascular endothelial cells, the predominant isoform expressed in vasculature and the most potent vasoconstrictor currently known. ET-1 also has inotropic, chemotactic and mitogenic properties. In addition, it influences salt…
Angiotensin II (Ang II) is considered the major final mediator of the renin-angiotensin system. The actions of Ang II have been implicated in many cardiovascular conditions, such as hypertension, atherosclerosis, coronary heart disease, restenosis, and heart failure. Ang II can act through two different receptors: Ang II type 1 (AT(1)) receptor and Ang II type…
An elevation in angiotensin II (Ang II) levels is a common occurrence in a diverse number of cardiovascular diseases including hypertension, hypercholesterolaemia, atherosclerotic coronary artery disease, left ventricular hypertrophy (LVH), heart failure and diabetes. An important effect of Ang II is activation of the NAD(P)H oxidase, a major source of reactive oxygen species (ROS) production…
Transportation Research Record: Journal of the Transportation Research Board
Work, Employment and Society
Autism
Communication Research
Educational and Psychological Measurement
Environment and Planning D: Society and Space
Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine
Journal of Composite Materials
